-
Mashup Score: 0Why publish - 3 day(s) ago
Discover the top 5 reasons to publish your research with EP Europace EP Europace – EHJ Arrhythmias and Electrophysiology is an official, fully open access jour
Source: academic.oup.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 4
AbstractBackground and Aims. Since the introduction of direct oral anticoagulant (DOAC) for atrial fibrillation (AF) therapy, inappropriate and/or underdosing o
Source: academic.oup.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Characteristics of patients with #AF and #DOAC inappropriate dosing 👉 https://t.co/2aC5ycHivI @EuropaceEiC @GiulioConte9 @Dominik_Linz @FraSantoroMD @AndyZhangMD @marcovitoloMD @MBergonti #Europace #arrhythmias https://t.co/3EyJu5yk8e
-
-
Mashup Score: 5Lead Management in Patients Undergoing Percutaneous Tricuspid Valve Replacement or Repair: A “Heart Team” Approach - 6 month(s) ago
Abstract. Clinically significant tricuspid regurgitation (TR) has historically been managed with either medical therapy or surgical interventions. More recently
Source: academic.oup.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Lead Management in Patients Undergoing Percutaneous Tricuspid Valve Replacement or Repair 👉 https://t.co/TBpiQZxmND @EuropaceEiC @GiulioConte9 @Dominik_Linz @FraSantoroMD @AndyZhangMD @marcovitoloMD #Europace #arrhythmias #TVR https://t.co/t2Cghhtgj0
-
-
Mashup Score: 4
AbstractBackground and Aims. Since the introduction of direct oral anticoagulant (DOAC) for atrial fibrillation (AF) therapy, inappropriate and/or underdosing o
Source: academic.oup.comCategories: Cardiologists, Latest HeadlinesTweet-
Our national survey is online at #Europace. Inappropriate dose of #DOAC in real world. Open access. Thanks to all cardiologists of @CNCFCardio and #SNC who have participated. #AF https://t.co/FbudLBr4i6
-
-
Mashup Score: 13
AbstractAims. Recurrence of arrhythmia after catheter ablation of atrial fibrillation (AF) in the form of atypical atrial flutter (AFL) is common among a signif
Source: academic.oup.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Advanced atrial cardiomyopathy assessed by #CMR is associated with arrhythmia recurrence after #AF ablation 👉 https://t.co/FDmdYB3R9A @EuropaceEiC @GiulioConte9 @Dominik_Linz @FraSantoroMD @AndyZhangMD @marcovitoloMD #Europace #arrhythmias #AF #CMR https://t.co/mFfnrZzJCT
-
-
Mashup Score: 2Optimal left ventricular ejection fraction in risk stratification of patients with cardiac sarcoidosis - 7 month(s) ago
AbstractAims. Identifying patients with cardiac sarcoidosis (CS) who are at an increased risk of sudden cardiac death (SCD) poses a clinical challenge. We sough
Source: academic.oup.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Optimal #LVEF cutoff in risk stratification of patients with cardiac #sarcoidosis 👉 https://t.co/t04fqLEkKT @EuropaceEiC @GiulioConte9 @Dominik_Linz @FraSantoroMD @AndyZhangMD @marcovitoloMD #Europace #arrhythmias #LVEF #Europace https://t.co/3IUZFvmynH
-
-
Mashup Score: 46Outcomes of patients with atrial fibrillation on oral anticoagulation with and without heart failure: the ETNA-AF-Europe registry - 7 month(s) ago
AbstractBackground and Aims. Heart failure (HF) is a risk factor for major adverse events in atrial fibrillation (AF). Whether this risk persists on non-vitamin
Source: academic.oup.comCategories: Cardiologists1, Latest HeadlinesTweet-
RT @ESC_Journals: Outcomes of patients with #AF on oral anticoagulation with and without #HF 👉 https://t.co/lGIPXql2cg @EuropaceEiC @Giuli…
-
Outcomes of patients with #AF on oral anticoagulation with and without #HF 👉 https://t.co/lGIPXql2cg @EuropaceEiC @GiulioConte9 @Dominik_Linz @FraSantoroMD @AndyZhangMD @marcovitoloMD #Europace #arrhythmias #HF #AF #OAC https://t.co/yVpQi24eUN
-
-
Mashup Score: 2Mind the gap: leak currents and induced pluripotent stem cell–derived cardiomyocytes in translational cardiac electrophysiology - 8 month(s) ago
This editorial refers to ‘Leak current, even with gigaohm seals, can cause misinterpretation of stem cell-derived cardiomyocyte action potential recordings’ by
Source: academic.oup.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Leak currents and induced pluripotent stem cell-derived cardiomyocytes in translational cardiac electrophysiology 👉 https://t.co/h6ZSsBbNUP @EuropaceEiC @GiulioConte9 @Dominik_Linz @FraSantoroMD @AndyZhangMD @marcovitoloMD #hiPSC #Europace #arrhythmias #translational https://t.co/m9oozWezI1
-
-
Mashup Score: 3EP Europace - 8 month(s) ago
An official journal of the European Society of Cardiology. Publishes top quality European and international original scientific work and reviews in the fields of Arrhythmias, Pacing and Cellular Electrophysiology.
Source: academic.oup.comCategories: General Medicine News, Latest HeadlinesTweet-
In case you missed our announcement during the busyness of the #ESCCongress, don’t miss the #Europace 25th anniversary issue that is now available online, featuring a series of state-of-the-art reviews commissioned by the Editorial Board: https://t.co/wCSzi5V3L2 @EuropaceEiC https://t.co/JREyJSskKa
-
-
Mashup Score: 2Modern subcutaneous implantable defibrillator therapy in patients with cardiomyopathies and channelopathies: data from a large multicentre registry - 8 month(s) ago
AbstractAims. Patients with cardiomyopathies and channelopathies are usually younger and have a predominantly arrhythmia-related prognosis; they have nearly nor
Source: academic.oup.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Long-term outcomes of S-ICD in patients with channelopathies and cardiomyopathies 👉 https://t.co/fqBKFeg5wA @EuropaceEiC @GiulioConte9 @Dominik_Linz @FraSantoroMD @AndyZhangMD @marcovitoloMD #genetics #Europace #S-ICD https://t.co/q7OrG9CMtc
-
Experience the benefits of open access publishing, an excellent reputation, global visibility, and much more when you publish with #Europace. Learn more about the benefits and join our author community: https://t.co/hzG6TOClcz @EuropaceEiC https://t.co/brxBJZRjN2